Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00691132 · ClinicalTrials.gov registry record · Phase 2
Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 107
- Enrollment target
NCT00691132 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 107 participants.
The verdict
NCT00691132, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 107 participants
- Enrollment target
Study Summary
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of phenethyl isothiocyanate may prevent lung cancer in people who smoke cigarettes. PURPOSE: This randomized clinical trial is studying phenethyl isothiocyanate to see how well it works in preventing lung cancer in smokers.
Interventions
- OTHER placebo
- DRUG phenethyl isothiocyanate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2009-02 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00691132
The ClinicalTrials.gov registry entry for NCT00691132 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00691132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00691132 about?
NCT00691132 is a clinical study titled "Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers". RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of phenethyl isothiocyanate may prevent lung cancer in people who smoke cigarettes. PURPOSE: This randomized clinical trial is studying phenethyl isothiocyanate to see how well it works in preventing lung ca...
What is the current status of trial NCT00691132?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 107 participants. The study started on 2009-02. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00691132?
The interventions under investigation include: placebo (OTHER), phenethyl isothiocyanate (DRUG).
Who is sponsoring clinical trial NCT00691132?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.